S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Outlines Drug-Price Reform
S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Outlines Drug-Price Reform · Investor's Business Daily

In This Article:

Pharmaceutical stocks boomeranged Monday after Trump signed an executive order tying drug prices in the U.S. to international price tags.